LifeVantage raises FY25 revenue view $235M-$245M from $200M-$210M

The Company now expects revenue in the range of $235 million to $245 million in fiscal 2025 compared to prior revenue guidance of $200 million to $210 million. “Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to quickly ramp supply chain and fulfillment capacity to meet the robust demand,” said Steve Fife, President and CEO of LifeVantage (LFVN). “We also saw significant growth in Active Accounts driven by the highest number of enrollments in a quarter since third quarter of fiscal 2019. We look forward to providing more details, including our profitability outlook, when we report our fiscal Q2 results in early February. With business momentum strong, we remain well positioned to deliver significant growth and shareholder value.”